Log In
Print
BCIQ
Print
Print this Print this
 

KBSA301

  Manage Alerts
Collapse Summary General Information
Company Kenta Biotech Ltd.
DescriptionHuman mAbs against Staphylococcal alpha toxin generated using the MabIgX technology
Molecular Target S. aureus exotoxin
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today